Annual Conference Speakers
Dr. Rudolf Bauer
Rudolf Bauer studied Pharmacy at the Ludwig-Maximilians Universität in Munich where he also obtained his PhD and wrote his habilitation. From 1993 until 2002 he was Professor at the University of Dusseldorf in Germany, before moving to Austria, where he is now Head of the Institute of Pharmaceutical Sciences at the University of Graz. His research focuses on Traditional Chinese Medicine, inflammation processes, plant metabolomics, screening and structure elucidation of plant active ingredients, quality control for herbal medicine, and activity and phytochemistry of Echinacea species. He has published more than 370 research papers and several books. He has been awarded, among others, the Egon-Stahl-Award of the Society for Medicinal Plant Research, the International Award of the Belgian Society of Pharmaceutical Sciences and the Norman R. Farnsworth Excellence in Botanical Research Award of the American Botanical Council.
Dr. Bruno David
Director Natural Substances, R&D Sourcing & Botany at Pierre Fabre Research Institute
Bruno David is a pharmacist and chemist by training (DPharm from Dijon University and PhD in Phytochemistry from CNRS ICSN Gif sur Yvette, and Pharmacology from CNRS IPBS Toulouse (Pharmacology and Toxicology Laboratory). He began his career as a visiting lecturer at the University Malaya and as a lecturer at the Faculty of Pharmacy at Paris XI.
Bruno joined Pierre Fabre Pharmaceutical Group in 1990 to lead the phytochemistry group. Between 1998 and 2007, he was in charge of the Natural Products Drug Discovery joint team (Pierre Fabre Research Institute/CNRS/IRD) involved in High Throughput Screening. Since 2007, he has been the Director of Natural Products, R&D Sourcing & Botany. Member of the French National Academy of Pharmacy and of many scientific associations, he has coauthored more than 60 publications, books and patents. He also obtained the University Professor Habilitation in 2000. He is also active in the field of Biodiversity and legal certainty (Member of the Strategic Orientation Council of the Foundation for Research on Biodiversity) and of many professional federations and groups dealing with biodiversity Access and Benefit Sharing (ABS) issues (LEEM, FEBEA, Cosmetics Europe, UNITIS…). He acts also an ABS expert for the French Ministry of Research and the European Commission.
Dr. Dugald Seely
Ottawa Integrative Cancer Centre, University of Ottawa
Dugald Seely is a naturopathic doctor and clinician scientist whose focus is on the application and evaluation of integrative oncology. Embodying a synthesis of evidence based complementary medicine with conventional medicine, integrative oncology offers a path for improved clinical care that is obvious to the conscientious practitioner and that best supports patients in the way they most need. Dr. Seely seeks to build a richer integration of this medicine within the health care system as a respected path for practitioners and researchers and ultimately for patients to be best served.
Dr. Seely is the founder and executive director of the Ottawa Integrative Cancer Centre (OICC) and executive director for the department of research & clinical epidemiology at the Canadian College of Naturopathic Medicine. Dr. Seely is an affiliate investigator at the Ottawa Hospital Research Institute; Adjunct Professor with the Faculty of Medicine at the University of Ottawa; Integrative Oncology Section Editor for the journal Current Oncology; and Vice President of the Oncology Association of Naturopathic Physicians. In research, Dr. Seely has led numerous clinical studies and synthesis reviews having published over 70 peer-reviewed papers. Seely is a frequent speaker and is actively engaged in the research community through a number of associations. In clinic, Dr. Seely sees patients three days a week at the OICC and is thrilled to be able to combine his passion for research and in the service of the patients he cares for.
Elisabeth Patterson joined Dionne Schulze law firm in 2010. She advises mostly First Nation and Inuit governments and organisations in Québec on a broad range of subjects, including Aboriginal, commercial and international law, as well as governance, environmental assessment, and the duty to consult and accommodate.
Elisabeth Patterson also assists clients by negotiating agreements, often in the context of social economy projects or economic development on Indigenous lands. She also advises concerning research ethics, privacy, and the protection of Indigenous data and knowledge.
Elisabeth Patterson frequently presents on the above subjects in a professional or community context. She is involved in legal education and human rights trials in Latin America with Lawyers without Borders Canada.
Dr. Daniel F. Gallego-Pérez is a physician with a specialty in alternative therapies, and a Doctor of Public Health candidate at Boston University. Since medical school, he has been interested in the range of possibilities that exist at the intersection of traditional, complementary, and integrative medicine and public health. He worked as a general practitioner and nutrition program coordinator in the Buduburam Refugee Camp, Ghana, between 2004 and 2008. He participated in the design and implementation of a pilot project to develop complementary medicine services in public hospitals in Bogota, Colombia, between 2009 and 2013. He has been consulting for the Pan American Health Organization since 2015, first at the country office in Nicaragua, and later at the regional office in Washington DC, where he assists health care systems strengthening and transformation processes, including the integration of traditional and complementary medicine. He is currently the chair-elect of the Integrative, Complementary, and Traditional Health Practices (ICTHP) Section of the American Public Health Association (APHA).
Timothy Hodges is Professor of Practice in Global Governance at McGill University’s Institute for the Study of International Development (ISID), where his work focuses on environmental global governance, and the negotiation and implementation of international sustainable development treaties by Indigenous Peoples, governments and stakeholders.
Professor Hodges is a former career Canadian diplomat, with a focus on environmental, economic, and trade policy issues including, for example, in the UN General Assembly, WTO, UN Convention on Biological Diversity (CBD), UN Framework Convention on Climate Change, UN Food and Agricultural Organization, UNESCO, OECD, Concurrently, he is Principal at Timothy J Hodges & Associates — an international consultancy providing confidential strategic advisory and leadership services to governments, private non-profit organizations, industry, and Indigenous and local communities.
He served as Co-Chair, of the intergovernmental negotiating committee for the United Nations treaty on Access and Benefit Sharing of Genetic Resources and Traditional Knowledge (i.e., the Nagoya Protocol) and was the founding Chair of Canada’s Federal/Provincial/Territorial Committee on Access and Benefit Sharing. Professor Hodges is past President of Professional Association of Foreign Service Officers (PAFSO).
DIPM, GAICD, FIML, MIOD
Mr Pollard is a recognised leader in scientifically proven natural medicines.
For the past 5 years he has had the position of Chairman of the Natural Health Science Foundation (NHSF), a New York incorporated Not For Profit. The NHSF is a global network of scientists, researchers, clinicians, companies and health professional associations who are dedicated to developing the evidence base of natural health solutions and promoting the acceptance of specific evidence natural health products into mainstream healthcare globally.
Pollard has worked for 33 years in the global medicine market. For 18 of those years he was founder and CEO of Soho Flordis International, a natural medicine company with sales in over 55 countries, manufacturing sites in Europe and North America and an unrivalled record of investing in 12 clinical trials on specific products.
Prof Dr Werner Knöss has been head of the licensing department 4 “Complementary and Alternative Medicines and Traditional Medicines” at the Federal Institute for Drugs and Medical Devices (BfArM, Germany) since 2005. He was research coordinator at BfArM from 2004 to 2012. Since March 2017 he is also head of the unit “Cannabis Agency” at BfArM. Since November 2018 he was appointed “Permanent Deputy to the President of BfArM”. Prof Dr Knöss completed his postgraduate studies in pharmaceutical biology in 1990. In 2012 he was appointed extraordinary Professor in Pharmaceutical Biology, University of Bonn, Germany. From 2005 he was appointed Visiting Professor to the School of Pharmacy, University College of London. In 2013, 2015, 2016, 2017 and 2019 he was teaching postgraduate courses at the Institute of Pharmacy, University of Innsbruck, Austria. From 2010-2016, he was chairperson of the Committee on Herbal Medicinal Products (European Medicines Agency), German Delegate to the Homeopathic Medicinal Products Working Group (Heads of Medicines Agencies, EU) and member of the CEP Steering Committee (European Pharmacopeia) and the Scientific Coordination Board (EMA). Prof Dr Knöss is chairperson of the German Homeopathic Pharmacopeia Commission since 2012, the Homeopathic Manufacturing Methods Working Group, and the committee on regulatory affairs of the Society of Medicinal Plants and Natural Product Research since 2017. In 2018, he was appointed Vice-Chair of the Steering Group of the International Regulatory Cooperation on Herbal Medicinal Products (WHO).
Shelley brings over 20 years’ experience in the Canadian innovation, commercialization and investment environment, both as an entrepreneur and as a champion within not for profit and academic settings. As CEO of Natural Products Canada, a multi-partner, pan-Canadian organization, she provides strategic direction and oversight, and leads the development of collaborative partnerships with investors, corporations, and government support agencies. In previous roles, Shelley has helped researchers and companies navigate commercialization hurdles such as regulatory, IP, scale-up, R&D, and financing. Prior to NPC, Shelley was Chief Executive Officer of Synapse, a not-for-profit organization responsible for the University of Prince Edward Island’s applied research and industry services.
Shelley received an MSc in Medicine and an MBA from Memorial University. She has served on innovation-related boards and committees such as the Aquaculture Association of Canada, Pan American Marine Biotechnology Association, Newfoundland and Labrador Association of Technology Industries, the Genesis Centre (NL), and the Natural Health Products Research Society, and currently serves on the board of Springboard Atlantic.
After more than thirteen years in various positions, including VP Science and Innovation at Naturex, Dr. Bily is Director of Integrated Solutions at Givaudan with research and development roles in the field of botanical specialty ingredients, including the development and implementation of sustainable practices and green technologies.
Prior to retiring, Gloria was Secretariat coordinator of Aboriginal Traditional Knowledge with the Committee on the Status of Endangered Wildlife in Canada (COSEWIC), where she has also contributed more than a decade of service as a a member of the Aboriginal Traditional Knowledge Subcommittee. Ms. Goulet is Metis from the Red River region of Manitoba. She was nominated by the Metis National Council and was the Manitoba lead for Woodland Boreal Caribou recovery consultations. She participated in the Naskapi Nation of Kawawachikamach Eastern wolverine recovery workshop. While working with the Secretariat, Gloria provided supervision and facilitated support for a pilot project by an Aboriginal student- Wolverine ATK review. Gloria has produced a number of ATK Source and ATK Assessment reports. She has a M.Sc. in Zoology and has taught university level courses to Aboriginal students on both university campuses and Manitoba reserves. She developed Aboriginal science teaching kits for early years students. Gloria researched and submitted reports to Parks Canada on the status of gray wolves in southwestern Manitoba. She co-authored a number of peer-reviewed publications and authored reports, conference presentations and popular articles related to that research. Gloria currently lives on the East shore of Lake Winnipeg. She has two adult children who are proud of their Metis heritage and contribute to Indigenous communities.